The use of Crizotinib to inhibit the activity of MET, a tyrosine kinase that is abnormal in a number of tumors.The use of Erbitux and Vectibix to inhibit epidermal growth factor receptors that are commonly expressed in cancer cells.The use AmpliChip®CYP450 assay to asses risks in course of cancer and create adequate treatment and prognosis.The use of warfarin to inhibit expression of several genes, particularly CYP2C9 and VKORC1.The use OncotypeDX® assay to analyze the expression (amount of mRNA) in cancer samples.The use of Herceptin for the treatment of breast cancer.
